Evidence map›Paper›PMID 35136538›Full record

ArticleJournal of healthcare engineering2022

Clinical Observation of Salvianolic Acid Combined with Panax Notoginseng Saponins Combined with Basic Nursing Intervention on Cerebral Ischemia-Reperfusion Injury in Rats.

Zhaopeng Zheng, Shanshan Liang, Shasha Sun, Pengfei Liu, Ling Yu

Open access · hybridAbstract read
In one paragraph

Article in Journal of healthcare engineering, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Zhaopeng ZhengHealth Management Department, Jiaozhou Central Hospital, Qingdao 266300, China.
Shanshan LiangDepartment of Neurology (I), Affiliated Qingdao Central Hospital, Qingdao University, Qingdao 266042, China.
Shasha SunDepartment of Neurosurgery, Affiliated Qingdao Central Hospital, Qingdao University, Qingdao 266042, China.
Pengfei LiuDepartment of Neurology, Zhangqiu District People's Hospital, Jinan 250200, China.
Ling YuDepartment of Neurology, Yantaishan Hospital, Yantai 26400, China.ORCID 0000-0003-4033-2408
Qingdao University · CNShuozhou Central Hospital · CNYantaishan Hospital · CNZhangqiu City People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo analyze the clinical observation of salvianolic acid combined with panax notoginseng saponins combined with basic nursing intervention on cerebral ischemia-reperfusion injury in rats and its effects on the expression of apoptosis-related proteins Bcl-2, Bax and caspase-3.

methodsA total of 72 male Wistar rats were randomly divided into sham, ischemia/reperfusion (I/R), edaravone (Eda), salvianolic acid (SA), panax notoginseng saponins (PNS), and SA+PNS group. After administration for 5 days, the neurological function, cerebral infarction volume, brain index, and brain water content of rats were observed. ELISA kit assay was applied to measure the levels of IL-1

resultsCompared with sham group, the mNSS score, brain index, brain water content, infarction volumes, MDA activity, and the levels of IL-6, IL-8, TNF-

conclusionsSA, PNS and they combined with basic nursing have protective effects on cerebral I/R injury, and the combination with basic nursing has better effects than that used alone. The mechanism may be to regulate the expression of downstream apoptotic proteins by inhibiting the TLR4/NF-

Indexed as

Panax notoginsengReperfusion InjurySaponinsAlkenesAnimalsbcl-2-Associated X ProteinCaspase 3FemaleHumansInfarctionInterleukin-6Interleukin-8MaleNF-kappa BPolyphenolsRatsAlkenesbcl-2-Associated X ProteinCaspase 3Interleukin-6Interleukin-8NF-kappa BPolyphenolssalvianolic acidSaponinsSuperoxide DismutaseTumor Necrosis Factor-alphaWater

Identifiers

PMID35136538
PMCPMC8818411
OpenAlexW4210779743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.